Governance Committee

The evolution of the Ontario Institute for Cancer Research (OICR) and the development of distinct research programs have created a need for ethics oversight of OICR’s own research. Most of the OICR project activities will be external to OICR and will have the necessary REB supervision; however, OICR-funded research or OICR researcher activities may involve OCREB oversight. OCREB currently serves the OICR’s Ontario Tumour Bank (OTB). To ensure the ongoing independence of OCREB decision-making, a Governance Committee was created to replace the previous OCREB Advisory Committee. This OCREB Governance Committee was established by and reports directly to the OICR Board of Directors. OCREB Governance Committee Terms of Reference


Raphael Saginur

Raphael Saginur, Chair, Ottawa Hospital Research Ethics Board;
Raphael Saginur, Chief, Division of Infectious Diseases, Ottawa Hospital Civic Site

Dr. Saginur is Chair of the Ottawa Hospital Research Ethics Board and Head of the Division of Infectious Diseases at the Civic Campus, Ottawa Hospital. He chairs the Governance Committee of the Ontario Cancer Research Ethics Board (OCREB), of which he was a founder. He sits on the Boards of Clinical Trials Ontario and the Network of Clinical Research Networks, as well as the Institute Advisory Board of the Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research (CIHR). Dr. Saginur was the founding president of the Canadian Association of Research Ethics Boards, with the support of the three federal funding councils, CIHR, NSERC and SSHRC. He is actively involved in the development of the REB system to better address the needs of study participants, investigators, sponsors and regulators. He has developed web-based educational programs in research ethics. Current research projects relate to the governance of human subjects research; consent in research; and oversight of multi-centre trials. He has advised the Ontario Institute of Cancer Research and CIHR regarding ethics review of multi-centre trials. He is an infectious disease clinician and Past President of the Canadian Foundation for Infectious Diseases (CFID).

Dr. Saginur graduated from Dartmouth College (AB, Psychology) and McGill University (MD, CM). He trained in Internal Medicine, Medical Microbiology and Infectious Disease at McGill University and Tufts University.

Back to Top

Geneviève Dubois-Flynn

Geneviève Dubois-Flynn, Manager and Senior Advisor, Canadian Institutes of Health Research Ethics Office

Manager and Senior Advisor at Canadian Institutes of Health Research (CIHR) Ethics Office. Geneviève Dubois-Flynn has a license ès droit international from Université de Paris XI and a PhD in philosophy from Université Laval. After teaching several courses at the University of Ottawa, including bioethics, and working at the National Council on Ethics in Human Research for two years, Geneviève joined CIHR in 2002. Geneviève has been working in the areas of governance of ethics in research involving humans and conflict of interest, and more recently on research involving Aboriginal Peoples and global health and ethics. She has been the ethics expert of the University of Ottawa Research Ethics Board for health sciences and sciences for several years and is now the HealthBridge REB Vice- Chair.

Back to Top

Michael McDonald

Michael McDonald, Professor Emeritus of Applied Ethics, the W. Maurice Young Centre for Applied Ethics at the University of British Columbia

Michael McDonald was the first occupant of the Maurice Young Chair of Applied Ethics in the W. Maurice Young Centre for Applied and served as the Centre’s founding director. Michael’s current research is focused on ethical issues in health research particularly on governance issue and the experiences of human subjects in health research. In 2009, the Canadian Bioethics Society gave its Lifetime Achievement Award to McDonald for his "outstanding contribution to the Healthcare Ethics in Canada". In 2006, the Certified General Accountants Association of Canada presented McDonald with the designation of Honorary Certified General Accountant for his contribution to professional ethics education for the Association. He has written on the ethics of research involving human subjects, cross-cultural ethics, community rights, business and professional ethics and the place of ethics in contemporary society. He continues to play a leadership role in the development of a significant Canadian capacity in applied ethics. He currently heads two websites: QI for Research Ethics (http://www.researchethicssurvey.ca/) and the Stem Cell Network Ethics Education website (http://www.stemcellethics.ca/).

Back to Top

Derek Cathcart

Derek Cathcart , Partner, First Canadian Investment Properties and Managing Partner at Cathcart & Associates

Partner at First Canadian Investment Properties and Managing Partner at Cathcart & Associates. Derek Cathcart became associated with First Canadian in December 2006 after holding senior management positions with domestic and global financial institutions in corporate/investment banking including TD Financial Group and ABN AMRO. Derek has extensive experience in corporate lending, investment banking and proprietary investing activities in Canada, USA, Europe, New Zealand and Australia. He specializes in advising clients on limited recourse project finance (including 3P), mergers/acquisitions and divestitures in industries ranging from owner-managed businesses to multinational companies with respect to debt and equity financings, restructurings, business and securities valuations and fairness opinions. Derek is a graduate of University of Western Ontario's Richard Ivey School of Business, where he received an Honours BBA and an MBA. In addition, Derek is an active member of the University Health Network Research Ethics Board as well as having earned the Certified Management Accountant (Ontario) designation.

Back to Top

Christopher Henley

Christopher M. Henley, Founder and President, Henley Capital Corporation

Click here to read Mr. Henley's biography on the Henley Capital Corporation website.

Back to Top